JLJing Li

Jing Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jing Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Bing Zhang

    Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China

    1 shared publication
  • Bing Zhang

    Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China

    1 shared publication
  • Fei Chen

    Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China

    1 shared publication
  • Li Hong

    Department of Clinical Nutrition, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine

    1 shared publication
  • Qihui Shao

    Department of Clinical Nutrition, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China

    1 shared publication
  • Wenxi Zhu

    Fujian Children’s Hospital (Fujian Branch of Shanghai Children’s Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou 350014, China

    1 shared publication

Latest Publications

  • Open Access

    ApoE and Fibroblast–Macrophage Interaction in the Aganglionic Segment of Hirschsprung’s Disease-Associated Enterocolitis

    by Qihui Shao, Zhulin Wang, Yifan Fang, Jing Li, Wenxi Zhu, Bing Zhang, Fei Chen, Zhilong Yan, Zhiyan Zhan, Li Hong

    Background: The pathogenesis of Hirschsprung’s disease-associated enterocolitis (HAEC) remains unclear. Currently, no definitive studies have elucidated the communication between intestinal macrophages and fibroblasts during the development of HAEC, nor their specific functional roles in this process. Methods: The first step is utilizing single-cell transcriptomics and spatial transcriptomic sequencing techniques to validate the phenotypes and corresponding spatial location characteristics of intestinal fibroblasts in the patient with HAEC. The second is verifying the mechanism whereby specific subtypes of fibroblasts and macrophages communicate via apolipoprotein E (ApoE) and modulate corresponding inflammatory pathways using co-culture, Western blot and other molecular biology techniques. Results: As HAEC progressed, JUN expression was significantly upregulated in CTHRC1+PRRX1+ fibroblasts enriched in the submucosal layer in the aganglionic segment. In vitro experiments showed JUN-overexpressing 3T3-L1 cells exhibited increased ApoE secretion. ApoE may interact with macrophages and potentially suppress their inflammation through the p38/MAPK and NF-κB pathways. Conclusions:CTHRC1+PRRX1+ fibroblasts and ApoE may represent a potential mechanistic target for future investigation into inhibiting the progression of the aganglionic segment in HAEC and treating colitis.